Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 2356 AL 2370

Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders

von Bernhardi R, Tichauer JE, Eugenín J.

J Neurochem. 2010 Mar;112(5):1099-114. doi: 10.1111/j.1471-4159.2009.06537.x. Epub 2009 Dec 10.

Sydenham's chorea in a girl with juvenile idiopathic arthritis treated with anti-TNFalpha therapy

Cimaz R, Gana S, Braccesi G, Guerrini R.

Mov Disord. 2010 Mar 15;25(4):511-4. doi: 10.1002/mds.22923.

Yeast unfolds the road map toward alpha-synuclein-induced cell death

Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Büttner S, Winderickx J.

Cell Death Differ. 2010 May;17(5):746-53. doi: 10.1038/cdd.2009.203. Epub 2009 Dec 18.

Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation

Gallina P, Paganini M, Lombardini L, Mascalchi M, Porfirio B, Gadda D, Marini M, Pinzani P, Salvianti F, Crescioli C, Bucciantini S, Mechi C, Sarchielli E, Romoli AM, Bertini E, Urbani S, Bartolozzi B, De Cristofaro MT, Piacentini S, Saccardi R, Pupi A, Vannelli GB, Di Lorenzo N.

Exp Neurol. 2010 Mar;222(1):30-41. doi: 10.1016/j.expneurol.2009.12.005. Epub 2009 Dec 21.

Knowledge-Based Analysis of Protein Interaction Networks in Neurodegenerative Diseases

Kanehisa M, Limviphuvadh V, Tanabe M.

In: Alzate O, editor. Neuroproteomics. Boca Raton (FL): CRC Press/Taylor & Francis; 2010. Chapter 9.

2-D Fluorescence Difference Gel Electrophoresis (DIGE) in Neuroproteomics

Diez R, Herbstreith M, Osorio C, Alzate O.

In: Alzate O, editor. Neuroproteomics. Boca Raton (FL): CRC Press/Taylor & Francis; 2010. Chapter 4.

Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea

Sabbagh MN, Shill HA.

Curr Opin Investig Drugs. 2010 Jan;11(1):80-91.

Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease

Ribeiro FM, Paquet M, Ferreira LT, Cregan T, Swan P, Cregan SP, Ferguson SS.

J Neurosci. 2010 Jan 6;30(1):316-24. doi: 10.1523/JNEUROSCI.4974-09.2010.

The clinical approach to movement disorders

Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR.

Nat Rev Neurol. 2010 Jan;6(1):29-37. doi: 10.1038/nrneurol.2009.196.

Psychogenic chorea associated with family history of Huntington disease

Fekete R, Jankovic J.

Mov Disord. 2010 Mar 15;25(4):503-4. doi: 10.1002/mds.22925.

[(18)F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine

Leung K.

2009 Nov 12 [updated 2010 Jan 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Dysregulated microRNAs in neurodegenerative disorders

Lau P, de Strooper B.

Semin Cell Dev Biol. 2010 Sep;21(7):768-73. doi: 10.1016/j.semcdb.2010.01.009. Epub 2010 Jan 18.

Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases

Orlacchio A, Bernardi G, Orlacchio A, Martino S.

Curr Med Chem. 2010;17(7):595-608. doi: 10.2174/092986710790416272.

'Diphasic' levodopa-induced chorea in multiple system atrophy

Tan EK, Chan LL.

Int J Clin Pract. 2010 Jan;64(1):126-8. doi: 10.1111/j.1742-1241.2006.00889.x.

A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea

Somenarain L, Jones LB.

J Psychiatr Res. 2010 Aug;44(11):694-9. doi: 10.1016/j.jpsychires.2009.12.006. Epub 2010 Jan 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias